Midterms didn’t appear to have huge impact, though predicted wins for Democrats could mean more regulation US tech stocks made a recovery on Tuesday afternoon after a selloff spooked investors over AI spending. Tuesday’s midterm elections didn’t appear to have a huge impact on Wall Street, though investors are predicting Democrats get at least a majority in the House and potentially gain seats in the Senate, which could lead to more AI regulation. Continue reading...
US tech stocks recover after selloff spooks investors over AI spending
Source: The Guardian
Original reporting
The Guardian: read the full reportFollow this story
Earlier reports and follow-ups on the same developing story.
Related stories
BBC Business
Poundland supplier 'will lose millions' if retailer collapses
One of Poundland's suppliers will lose millions if it collapses, while other suppliers have said they would go under.
CNBC
Treasury yields fall as investors crowd into bonds for safety amid election stock sell-off
Treasury yields fell on Tuesday night, as investors sought shelter from a sell-off in equity futures sparked by big victories from Democrats in the U.S. midterm elections.
CNBC
Novo raises full-year outlook as Wegovy pill sales impress
Novo posted quarterly earnings ahead of expectations early Wednesday as sales of its Wegovy pill blew past estimates
CNBC
Midterm Takeaways: Tech billionaires suffer horrible night as Democrats drub Republicans
Elon Musk's spending may have become a liability as voters in exit polls raised concerns about government corruption and the growing influence of billionaires.
The Guardian2 outlets
Rogue UK energy bosses and brokers face crackdown on mis-selling
Exclusive: Ofgem to be given powers to issue fines and rein in bonuses for executives who ‘reward themselves while customers suffer’ Energy bosses in the UK will have their bonuses curtailed when suppliers and brokers break the rules under a crackdown on mis-selling. Through the energy independence bill, which will be introduced on Wednesday, Ofgem will be given new powers to order compensation, impose fines and ban rogue operators that have pushed businesses and households into overpriced contracts. Continue reading...
The Guardian
Why pharma firms are going to Earth’s orbit in search of new cancer drugs
A space capsule 300 miles above us is growing the tiny crystals of a potential cancer drug in microgravity Roughly 300 miles above our heads, three washing machine-sized capsules are orbiting the Earth. Inside one of them, tiny crystals of a potential cancer drug are being grown in the weightlessness of space. The others are testing heat protection materials and navigation systems for when the capsules plunge back through Earth’s atmosphere at hypersonic speeds. Together, they represent a small but significant step towards what some hope will become a lucrative new industry: manufacturing drugs and other materials in space. The spacecraft belong to California-based Varda Space Industries. On 1 October, it launched two onboard the same rocket, followed by the third on 20 October. With a record three spacecraft now simultaneously in orbit for the first time, the company is edging closer to